News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Exposure to light at night does not increase breast cancer risk, major new study suggests

23/01/18

The prospective analysis of 105,866 women provides evidence against the 40 year old proposal that night-time light levels and breast cancer risk are linked.
ICR Logo
New treatment strategy could overcome drug resistance in testicular cancer

22/01/18

Men with testicular cancers called testicular germ cell tumours could benefit from a new combination of treatments if their chemotherapy stops working.
ICR Logo
Scientists zoom in to watch DNA code being read

17/01/18

Scientists have unveiled incredible images of how the DNA code is read and interpreted – revealing new detail about one of the fundamental processes of life.
Sir Richard Doll building in Sutton
The ICR and Cancer Research UK join forces with leading science and technology company in new drug discovery alliance

17/01/18

The deal follows previous drug discovery collaborations and a more recent successful target validation collaboration between Merck and Cancer Research UK’s Cancer Therapeutics Unit at the ICR.
Jonny Pettinger and others posing with cricket bats (547x410)
ICR PhD student chosen to speak at joint UK-India conference

16/01/18

Jonny Pettinger was one of just eight PhD students chosen from across the UK to speak, and was also given the chance to undertake a two-week research project.
logo
The ICR responds to the FDA approval of olaparib for women with BRCA-mutant​​ advanced breast cancer

12/01/18

The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been approved by the US Food and Drug Administration (FDA) for patients with advanced breast cancer.
Radiotherapy IMRT Jan Chlebik/the ICR
Scientists bring innovative microbeam radiation therapy for cancer treatment a step closer

08/01/18

Scientists have developed a new mathematical tool which will speed a smart new type of radiotherapy into the first patient trials.
Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID
Virus could treat brain tumours by boosting immune system

03/01/18

A virus injected directly into the bloodstream could be used to treat people with aggressive brain tumours, a major new study reports.
ICR Logo
Test reveals which breast cancer patients may benefit from targeted therapy

02/01/18

A new test could indicate which women with some breast cancer types are likely to benefit from targeted treatments, according to new research.
Dave Griffiths running past the ICR cheer point at the 2017 London marathon
Fundraiser ‘Hollywood’ Dave runs an incredible 11 marathons for the ICR this year

28/12/17

Inspirational fundraiser ‘Hollywood’ Dave Griffiths has finished a heroic 11 marathon challenge to raise money for the Institute of Cancer Research, London.
Delay in reforming European rules could deny thousands of children access to latest cancer drugs

22/12/17

Thousands of children with cancer across Europe could miss out on the latest targeted treatments because of delays reforming outdated regulations, leading cancer research institutions, charities and expert bodies are warning.
ICR Logo
MRI could detect signs of more aggressive breast cancers

20/12/17

Magnetic resonance imaging (MRI) is able to detect indicators that a breast tumour is likely to be more aggressive, researchers have found.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.